STOCK TITAN

Ionis (IONS) insider files to sell 1,625 shares valued $112,725

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice shows a proposed sale of 1,625 common shares by an insider who acquired them as restricted stock units on 04/15/2025. The shares are to be sold through Stifel Nicolaus & Company on 10/06/2025 with an aggregate market value of $112,725.00 based on the filing. The issuer reports 159,391,229 shares outstanding.

The filer disclosed prior insider sales totaling 60,000 shares during the past three months (sales on 09/03/2025, 09/05/2025, 09/09/2025, and 10/02/2025) generating $3,724,770.00 in gross proceeds. The current notice states the securities were paid for in cash at acquisition and were granted by the issuer as RSUs.

Positive

  • Securities were granted as restricted stock units, indicating standard equity compensation.
  • Sale uses a registered broker (Stifel Nicolaus), implying routine market execution.
  • Proposed sale value is $112,725.00, a modest amount relative to total shares outstanding.

Negative

  • Insider previously sold 60,000 shares in the past three months, generating $3,724,770.00, which may indicate continued insider selling activity.
  • Planned sale adds to recent disposals, potentially increasing near-term supply from this holder.

Insights

Small scheduled RSU sale with recent larger disposals.

The notice records a planned sale of 1,625 shares granted as restricted stock units on 04/15/2025

Recent activity shows 60,000 shares sold in the prior three months for $3,724,770.00, which may indicate ongoing vesting-driven or liquidity-motivated dispositions rather than a single large block sale.

Monitor reported sale dates around 10/06/2025 for execution and any additional filings that update the number of shares sold.

Transaction size is small relative to outstanding shares.

The current proposed sale has an aggregate value of $112,725.00 against reported outstanding shares of 159,391,229, representing a de minimis absolute position size on a company-wide basis.

Because the sale will be handled by a registered broker (Stifel Nicolaus), execution will follow market mechanisms; watch for a Form 4 or amended 144 showing actual execution and any variation from the planned 10/06/2025 timing.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does IONS Form 144 disclose about the planned sale?

It discloses a proposed sale of 1,625 common shares to be executed on 10/06/2025 through Stifel Nicolaus with an aggregate market value of $112,725.00.

How were the shares acquired by the seller in the IONS filing?

The shares were acquired on 04/15/2025 as restricted stock units (RSUs) and payment was recorded as cash at acquisition.

How many IONS shares have been sold by this person in the past three months?

The filing lists four prior sales totaling 60,000 shares on 09/03/2025, 09/05/2025, 09/09/2025, and 10/02/2025, with gross proceeds of $3,724,770.00.

What is the issuer's share count in the Form 144?

The filing reports 159,391,229 shares outstanding for the issuer.

Who is the broker handling the planned sale in the IONS Form 144?

The broker named is Stifel Nicolaus & Company Inc based in St. Louis, Missouri.
Ionis Pharmaceuticals

NASDAQ:IONS

IONS Rankings

IONS Latest News

IONS Latest SEC Filings

IONS Stock Data

12.81B
160.75M
0.65%
108.48%
6.59%
Biotechnology
Pharmaceutical Preparations
Link
United States
CARLSBAD